MwanzoPTCT • NASDAQ
add
PTC Therapeutics, Inc.
$ 43.23
Baada ya Saa za Kazi:(0.00%)0.00
$ 43.23
Imefungwa: 22 Nov, 16:02:33 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 42.89
Bei za siku
$ 42.74 - $ 44.10
Bei za mwaka
$ 20.75 - $ 46.98
Thamani ya kampuni katika soko
3.33B USD
Wastani wa hisa zilizouzwa
elfu 752.03
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 196.79M | 0.11% |
Matumizi ya uendeshaji wa biashara | 76.49M | -45.18% |
Mapato halisi | -106.65M | 19.79% |
Kiwango cha faida halisi | -54.20 | 19.87% |
Mapato kwa kila hisa | -1.36 | 22.06% |
EBITDA | -45.48M | 16.72% |
Asilimia ya kodi ya mapato | -8.84% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.02B | 247.13% |
Jumla ya mali | 1.84B | 46.22% |
Jumla ya dhima | 2.90B | 50.03% |
Jumla ya hisa | -1.05B | — |
hisa zilizosalia | 77.13M | — |
Uwiano wa bei na thamani | -3.13 | — |
Faida inayotokana na mali | -6.91% | — |
Faida inayotokana mtaji | -8.87% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -106.65M | 19.79% |
Pesa kutokana na shughuli | -76.99M | -430.28% |
Pesa kutokana na uwekezaji | -42.68M | -44.19% |
Pesa kutokana na ufadhili | -17.63M | -624.46% |
Mabadiliko halisi ya pesa taslimu | -128.75M | -198.83% |
Mtiririko huru wa pesa | -39.22M | -129.88% |
Kuhusu
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1 Jan 1998
Makao Makuu
Tovuti
Wafanyakazi
1,022
